RSI společnosti QSAM Biosciences
Jaká je hodnota metriky RSI společnosti QSAM Biosciences?
Hodnota metriky RSI společnosti QSAM Biosciences, Inc. je 68.60
Jaká je definice metriky RSI?
Index relativní síly (Relative strength index - RSI 14) je technický ukazatel, který se řadí mezi momentum indikátory a měří rychlost a změnu ceny. Jeho hodnota se pohybuje mezi 0 a 100 a používá se k charakterizování překupovaného a přeprodaného stavu.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI společností v sektoru Health Care sektor na OTC ve srovnání se společností QSAM Biosciences
Čemu se věnuje společnost QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Firmy s metrikou rsi podobnou společnosti QSAM Biosciences
- Hodnota metriky RSI společnosti Real Estate & E-Comm Split je 68.58
- Hodnota metriky RSI společnosti Templeton Global Growth Fund je 68.58
- Hodnota metriky RSI společnosti Dolly Varden Silver je 68.58
- Hodnota metriky RSI společnosti Majestic Gold je 68.58
- Hodnota metriky RSI společnosti TCW Strategic Income Fund Inc je 68.59
- Hodnota metriky RSI společnosti LHN je 68.59
- Hodnota metriky RSI společnosti QSAM Biosciences je 68.60
- Hodnota metriky RSI společnosti SK Telecom Co Ltd je 68.61
- Hodnota metriky RSI společnosti GFL je 68.61
- Hodnota metriky RSI společnosti EPR Properties je 68.61
- Hodnota metriky RSI společnosti Alembic Pharmaceuticals je 68.61
- Hodnota metriky RSI společnosti Marico je 68.62
- Hodnota metriky RSI společnosti Calnex Solutions Plc je 68.63